StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.42+0.17 (+5.23%)

Close on Nov 19, 2026Market cap $25.20MP/E –Yield –

Immutep free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -A$55.56M. The highest annual figure on record is -A$7.79M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$55.56M–
FY2025Jun 30, 2025-A$62.10M–
FY2024Jun 30, 2024-A$34.85M–
FY2023Jun 30, 2023-A$35.44M–
FY2022Jun 30, 2022-A$30.25M–
FY2021Jun 30, 2021-A$17.66M–
FY2020Jun 30, 2020-A$10.86M–
FY2019Jun 30, 2019-A$15.33M–
FY2018Jun 30, 2018-A$7.79M–
FY2017Jun 30, 2017-A$8.51M–
FY2016Jun 30, 2016-A$11.34M–

More Immutep figures

See a number that looks wrong?